Cargando…
Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease
Hypertension is commonly associated with autosomal dominant polycystic kidney disease (ADPKD), often discovered before the onset of renal failure, albeit the pathogenetic mechanisms are not well elucidated. Hyperaldosteronism in ADPKD may contribute to the development of insulin resistance and endot...
Autores principales: | Lai, Silvia, Petramala, Luigi, Mastroluca, Daniela, Petraglia, Emanuela, Di Gaeta, Alessandro, Indino, Elena, Panebianco, Valeria, Ciccariello, Mauro, Shahabadi, Hossein H., Galani, Alessandro, Letizia, Claudio, D’Angelo, Anna Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265756/ https://www.ncbi.nlm.nih.gov/pubmed/27442639 http://dx.doi.org/10.1097/MD.0000000000004175 |
Ejemplares similares
-
Autosomal dominant polycystic kidney disease combined with hypertrophic cardiomyopathy: A case report
por: Shen, Yingjing, et al.
Publicado: (2017) -
Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
por: Sans, Laia, et al.
Publicado: (2016) -
Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient
por: Shim, Kwang Eon, et al.
Publicado: (2020) -
Clinical characteristics and risk factors for kidney failure in patients with autosomal dominant polycystic kidney disease: A retrospective study
por: Park, Hanil, et al.
Publicado: (2022) -
Primary prevention of cardiovascular disease events with renin-angiotensin system blockade in autosomal dominant polycystic kidney disease dialysis patients: A nationwide cohort study
por: Lu, Chien-Lin, et al.
Publicado: (2021)